A Phase III, multi-center, placebo–controlled trial of Sorafenib (BAY 43-9006) in patients with relapsed or refractory advanced predominantly non squamous Non-Small Cell Lung Cancer (NSCLC) after 2 or 3 previous treatment regimens.


Grant Data
Project Title
A Phase III, multi-center, placebo–controlled trial of Sorafenib (BAY 43-9006) in patients with relapsed or refractory advanced predominantly non squamous Non-Small Cell Lung Cancer (NSCLC) after 2 or 3 previous treatment regimens.
Principal Investigator
Dr Ho, James Chung Man   (Principal investigator)
Co-Investigator(s)
Dr Wong King Yan Matthew   (Co-Investigator)
Dr Wang Kwan Ling Julie   (Co-Investigator)
Dr Lam Chung Mei Jamie   (Co-Investigator)
Dr Lam Chi Leung David   (Co-Investigator)
Duration
30
Start Date
2009-08-14
Completion Date
2012-02-13
Amount
354319
Conference Title
Presentation Title
Keywords
Non-small cell lung cancer, Sorafenib
Discipline
Cancer,Respiration
Panel
Medicine
Sponsor
Other projects
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2009/2010
Status
On-going